Evidence map›Paper›PMID 36472424›Full record

ArticleJournal of clinical microbiology2022

Multicenter Evaluation of the Cepheid Xpert GBS LB XC Test.

Phyu M Thwe, Matthew L Faron, David T Pride, Amorina Cruz, Derek Gerstbrein, Karen A Nahmod, Lindsay Bigham, Xiaotang Du, Xixi Lu, Stephanie Moya and 1 more

Open access · hybridAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Group B streptococci (GBS) strains evading molecular diagnostics showed novel chromosomal deletions encompassing the CAMP-factor (cfb) encoding gene.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Phyu M ThweDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0003-3250-9998
Matthew L FaronDepartment of Pathology, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
David T PrideDepartment of Pathology, University of California, San Diego, La Jolla, California, USA.
Amorina CruzDepartment of Pathology, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Derek GerstbreinDepartment of Pathology, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Karen A NahmodDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Lindsay BighamDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Xiaotang DuDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Xixi LuCepheid, Sunnyvale, California, USA.
Stephanie MoyaCepheid, Sunnyvale, California, USA.
Ping RenDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0002-4022-6667
The University of Texas Medical Branch at Galveston · USMedical College of Wisconsin · USMontefiore Medical Center · USUniversity of California San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early-onset neonatal sepsis due to Streptococcus agalactiae (group B Streptococcus [GBS]) infection is one of the leading causes of newborn mortality and morbidity. The latest guidelines published in 2019 recommended universal screening of GBS colonization among all pregnant women and intrapartum antibiotic prophylaxis for positive GBS. The updated procedures allow rapid molecular-based GBS screening using nutrient broth-enriched rectovaginal samples. Commercially available molecular assays for GBS diagnosis target mainly the

Indexed as

Pregnancy Complications, InfectiousStreptococcal InfectionsFemaleHumansInfant, NewbornPregnancySensitivity and SpecificityStreptococcus agalactiaeVaginagroup B Streptococcus (GBS)sensitivityspecificityXpert GBS LB XC test

Identifiers

PMID36472424
PMCPMC9769564
OpenAlexW4310776666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.